Literature DB >> 25755612

Nodule in Liver: Investigations, Differential Diagnosis and Follow-up.

Padaki N Rao1.   

Abstract

Conventional ultrasonogram of the abdomen being noninvasive, inexpensive and ubiquitously available is the first imaging modality that raises suspicion of HCC in a patient with chronic liver disease with or without cirrhosis. The lesions in liver particularly nodule are being recognized with increased frequency with the wide spread use of ultrasonogram as the initial investigation and computerized tomography and magnetic resonance imaging subsequently. Any nodule in a cirrhotic liver should be considered as hepatocellular carcinoma until otherwise proved. This approach certainly is helpful in diagnosing HCC at its earliest possible stage to offer meaningful curative measures be it transplant, resection or ablative therapy. After a nodule is detected on ultrasonogram the next imaging modality can be a contrast enhanced study (dynamic CT scan or an MRI) to see if are present or not. Two vital clues for diagnosis of HCC by contrast enhanced imaging are presence of arterial hypervascularity and washout which are considered as "classical imaging features". This sequence of events of arterial uptake followed by washout is highly specific for diagnosis of HCC by imaging. If the features are typical showing classical imaging features (i.e hypervascular in the arterial phase with washout in portal venous or delayed phase) the lesion should be treated as HCC biopsy is not necessary. Nodular lesions showing an atypical imaging pattern, such as iso- or hypovascular in the arterial phase or arterial hypervascularity alone without portal venous washout, should undergo further examinations with another contrast enhanced imaging. Biopsy is advisable for those lesions which do not show classical features on the imaging.

Entities:  

Keywords:  AASLD, American Association for Study of Liver Diseases; AFP, alphafetoprotein; ALT, alanine aminotransferase; APASL, Asia–Pacific Association for Study of Liver; AST, aspartate aminotransferase; CEA, carcino-embryonic antigen; CEUS, contrast enhanced ultrasound; CT, computerized tomography; DIA, digital image analysis; DW MRI, diffusion weighted magnetic resonance imaging; FDG, fludeoxyglucose; FISH, fluorescent in situ hybridization; FNA, fine needle aspiration; FNH, focal nodular hyperplasia; HBV, hepatitis B virus; HCC, hepatocellular carcinoma; HCV, hepatitis C virus; LDH, lactate dehydrogenase; MDCT, multidetector computerized tomography; MRI, magnetic resonance imaging; PEI, percutaneous ethanol injection; PET, positron emission tomography; PUO, pyrexia of unknown origin; RFA, radio frequency ablation; US, ultrasound; hepatocellular carcinoma; nodule liver; ultrasonogram

Year:  2014        PMID: 25755612      PMCID: PMC4284214          DOI: 10.1016/j.jceh.2014.06.010

Source DB:  PubMed          Journal:  J Clin Exp Hepatol        ISSN: 0973-6883


  28 in total

Review 1.  Focus on dysplastic nodules and early hepatocellular carcinoma: an Eastern point of view.

Authors:  Masamichi Kojiro
Journal:  Liver Transpl       Date:  2004-02       Impact factor: 5.799

2.  Improving the prediction of hepatocellular carcinoma in cirrhotic patients with an arterially-enhancing liver mass.

Authors:  Jorge A Marrero; Hero K Hussain; Hahn V Nghiem; Ramsey Umar; Robert J Fontana; Anna S Lok
Journal:  Liver Transpl       Date:  2005-03       Impact factor: 5.799

3.  Large (>or=2 cm) non-hypervascular nodules depicted on MRI in the cirrhotic liver: fate and implications.

Authors:  J S Yu; J J Chung; J H Kim; K W Kim
Journal:  Clin Radiol       Date:  2008-08-13       Impact factor: 2.350

4.  Value of fusing PET plus CT images in hepatocellular carcinoma and combined hepatocellular and cholangiocarcinoma patients with extrahepatic metastases: preliminary findings.

Authors:  Sakae Nagaoka; Satoshi Itano; Masatoshi Ishibashi; Takuji Torimura; Kenkichi Baba; Junji Akiyoshi; Junichi Kurogi; Satoru Matsugaki; Kinya Inoue; Nobuyoshi Tajiri; Akio Takada; Eiji Ando; Ryoko Kuromatsu; Hayato Kaida; Mina Kurogi; Hironori Koga; Ryukichi Kumashiro; Naofumi Hayabuchi; Masamichi Kojiro; Michio Sata
Journal:  Liver Int       Date:  2006-09       Impact factor: 5.828

5.  Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model.

Authors:  Xavier Forns; Sergi Ampurdanès; Josep M Llovet; John Aponte; Llorenç Quintó; Eva Martínez-Bauer; Miquel Bruguera; Jose Maria Sánchez-Tapias; Juan Rodés
Journal:  Hepatology       Date:  2002-10       Impact factor: 17.425

6.  Hepatocellular carcinoma in cirrhotic livers: double-contrast thin-section MR imaging with pathologic correlation of explanted tissue.

Authors:  Bobby Bhartia; Janice Ward; J Ashley Guthrie; Philip J Robinson
Journal:  AJR Am J Roentgenol       Date:  2003-03       Impact factor: 3.959

7.  Serum tumor markers for the diagnosis of cholangiocarcinoma in primary sclerosing cholangitis.

Authors:  J K Ramage; A Donaghy; J M Farrant; R Iorns; R Williams
Journal:  Gastroenterology       Date:  1995-03       Impact factor: 22.682

Review 8.  Needle track seeding following biopsy of liver lesions in the diagnosis of hepatocellular cancer: a systematic review and meta-analysis.

Authors:  M A Silva; B Hegab; C Hyde; B Guo; J A C Buckels; D F Mirza
Journal:  Gut       Date:  2008-07-31       Impact factor: 23.059

9.  Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: Prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma.

Authors:  Alejandro Forner; Ramón Vilana; Carmen Ayuso; Lluís Bianchi; Manel Solé; Juan Ramón Ayuso; Loreto Boix; Margarita Sala; María Varela; Josep M Llovet; Concepció Brú; Jordi Bruix
Journal:  Hepatology       Date:  2008-01       Impact factor: 17.425

10.  Management of hepatocellular carcinoma: an update.

Authors:  Jordi Bruix; Morris Sherman
Journal:  Hepatology       Date:  2011-03       Impact factor: 17.425

View more
  4 in total

1.  Spontaneous rupture of multifocal hepatocellular carcinoma: case report.

Authors:  Özkan Özen; Alptekin Tosun; Çiğdem Akgül
Journal:  Int Med Case Rep J       Date:  2015-08-17

2.  Diagnostic Imaging of Hepatocellular Carcinoma - A Pictorial Essay.

Authors:  Tomasz K Nowicki; Karolina Markiet; Edyta Szurowska
Journal:  Curr Med Imaging Rev       Date:  2017-05

3.  Identification of two distinct hereditary hemorrhagic telangiectasia patient subsets with different hepatic perfusion properties by combination of contrast-enhanced ultrasound (CEUS) with perfusion imaging quantification.

Authors:  Roland C Schelker; Kornelia Andorfer; Franz Putz; Wolfgang Herr; Ernst-Michael Jung
Journal:  PLoS One       Date:  2019-04-11       Impact factor: 3.240

4.  In vivo quantitative photoacoustic evaluation of the liver and kidney pathology in tyrosinemia.

Authors:  Guojia Huang; Jing Lv; Yong He; Jian Yang; Lvming Zeng; Liming Nie
Journal:  Photoacoustics       Date:  2022-09-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.